Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters. - Wikidata - awgldk - TriplyDB

Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

http://www.wikidata.org/entity/Q34613849

about

In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model ABCC5 is required for cAMP-mediated hindgut invagination in sea urchin embryos.Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.Nature and uses of fluorescent dyes for drug transporter studies.Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts.Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems.LysoTracker and MitoTracker Red are transport substrates of P-glycoprotein: implications for anticancer drug design evading multidrug resistance.Drug-resistant Th17 cells: culprits in steroid-refractory Crohn's disease?A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions.A Synthetic Hybrid Molecule for the Selective Removal of Human Pluripotent Stem Cells from Cell Mixtures.Dual pathways mediate β-amyloid stimulated glutathione release from astrocytes.Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1)

P2860

Q30583710-EB2F65C4-3F44-426D-8B7B-16D6DEA82D42 Q32186656-DD71AB48-5E4C-43C1-844C-23ADE813F073 Q33742497-84F310BE-AED8-4091-9A10-390D8F74CCEE Q34173709-106F251A-E857-4685-B740-272482346E5B Q35585361-A22B9B8F-B8FB-41F6-96C3-54C0BD46386E Q35847016-FB68B4EA-7547-4ED5-B88A-AD9CEB6EAF84 Q36245109-AFB3D763-6056-4B4C-9B83-17B208DEB667 Q36765399-2B9BD596-0C9C-493F-A693-CA206AC37D55 Q37483138-FC3A86B4-BAB9-416E-9D83-75272C65245E Q38518912-A20AE8CA-E94D-41EC-BB4C-1E2A11D85C11 Q38743568-9F0DA132-BF20-4517-993D-07DB4E9DA0FD Q46333054-FFE460AF-F972-4FF1-BFAE-3B24CE61F08B Q47362066-8C194001-5F32-428E-A85D-F0CF3B97DE31 Q47707597-DDCB7B9A-9D76-4568-93AB-3B681C0E7F4C Q48074137-56E91377-BC78-4421-909A-BC240FADDFF4 Q48226529-CD9D34DE-5F43-4ECB-9221-6ED36ACE79C8 Q52805014-D4514712-6792-428F-B6DC-2F61E2471F10 Q53478464-3B6CB9D1-E0A3-4830-A14D-8B256DF353FA Q57816977-744CC3C2-BE79-4ED8-A569-0871EB80A24B Q59126511-38DEE4C7-5614-4FF9-96A0-5ECB4EB3EE9A

P2860

Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

http://www.wikidata.org/entity/Q34613849

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@ast

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@en

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@nl

type

label

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@ast

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@en

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@nl

prefLabel

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@ast

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@en

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@nl

P1433

Q34613849-A3CF5A87-61FE-4E3A-A8F3-95F7BE77A9B6

P1476

Q34613849-CBB23D6B-2E2A-4AF4-9794-56107407026F

P2093

Q34613849-00E30570-9DBE-4228-94E8-7845D6B697CB

Q34613849-0DB823FF-8FF0-41B0-9B75-6429BFC4D60E

Q34613849-0E5AB434-F174-41BC-BC4F-17643EDB82CC

Q34613849-6F41206D-5FED-400A-BD86-58C907FB64E1

Q34613849-7447F554-4047-4B3E-A7FD-74055FC21FB6

Q34613849-7CF6DE2E-249B-44F4-9A9E-E921553C5D12

Q34613849-9040F4D7-C811-4965-BE00-7925F7F0732F

Q34613849-A0B7A94B-ACD0-4E43-A35F-C6A148C2C4AE

Q34613849-B0BF0879-7056-4A38-B450-CEB38233FF2A

Q34613849-C216F7F6-485B-4E51-A233-5905CB02FA53

P2860

Q34613849-014224DD-5797-48B5-BC9A-3AC33CDD80CD

Q34613849-0452C2AF-DA90-4DFB-9F04-77BFF3E32FA2

Q34613849-06356DA4-EC8E-41CC-BFE0-EB419EFD2A9E

Q34613849-0CC8D8A7-E72A-48E2-BCB3-AB508525E89C

Q34613849-119A9690-9E69-476D-8406-61B3E342A034

Q34613849-11A6EC94-8814-4C46-93CF-8A2A8BAD12D2

Q34613849-163F9019-1F74-449B-8C26-7E5271887B5F

Q34613849-24CA6306-919D-45B0-8AE9-CA6064F61C97

Q34613849-253A5A8B-64F6-4CA9-B279-B64DF28AA20F

Q34613849-2F2CAA63-91DC-460D-9551-C70C74E386B9

P304

Q34613849-5B1CCE9B-2A0A-4758-95AE-DA5D046D113D

P31

Q34613849-D2B73C65-7E14-49C6-BD3E-C1724ACE0B94

P356

Q34613849-8D3FF795-D9BD-4B19-A38A-F619165F4480

P407

Q34613849-6757B56A-3979-4770-BD19-AFB4D13CD980

P433

Q34613849-C8A53976-EAB7-4373-A9CF-7A751D70A8F3

P478

Q34613849-C4CA0101-91B5-49FF-AD92-5DB92D5CAEC8

P50

Q34613849-38437A77-9180-4025-B2E2-C20DC296B26B

Q34613849-461E0EF4-2A1C-4EE3-BF85-25BB6AB3D8B3

P577

Q34613849-AD10F835-8CC8-4E1A-9A52-3A15629DBF68

P5875

Q34613849-CBCF7CB9-F814-4846-8734-C38BB2D2E572

P698

Q34613849-7844743C-CCAC-4009-97BF-FE64BFB17D58

P932

Q34613849-24477766-4D36-428B-AC4B-857D664C17AF

P356

J.AB.2013.02.018

P1433

Analytical Biochemistry

P1476

Fluorescent substrates for flo ...... ABCC1, and ABCG2 transporters.

@en

P2093

Anna Waller

http://www.w3.org/2001/XMLSchema#string

Annette M Evangelisti

http://www.w3.org/2001/XMLSchema#string

Bruce S Edwards

http://www.w3.org/2001/XMLSchema#string

Dominique Perez

http://www.w3.org/2001/XMLSchema#string

George Tegos

http://www.w3.org/2001/XMLSchema#string

Irena Ivnitski-Steele

http://www.w3.org/2001/XMLSchema#string

J Jacob Strouse

http://www.w3.org/2001/XMLSchema#string

Larry A Sklar

http://www.w3.org/2001/XMLSchema#string

Mark B Carter

http://www.w3.org/2001/XMLSchema#string

Oleg Ursu

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters

Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site.

Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.

Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.

New inhibitors of ABCG2 identified by high-throughput screening

High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters.

Botryllamides: natural product inhibitors of ABCG2

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

P304

77-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AB.2013.02.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

437

http://www.w3.org/2001/XMLSchema#string

P50

Cristian G. Bologa

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235884586

http://www.w3.org/2001/XMLSchema#string

P698

23470221

http://www.w3.org/2001/XMLSchema#string

P932

3785545

http://www.w3.org/2001/XMLSchema#string